Quick10K

⚲

1847 Holdings

Filings

10-K	2020-12-31	Filed 2021-04-15
S-1	2020-10-30	Public Filing
10-Q	2020-09-30	Filed 2020-11-23
10-Q	2020-06-30	Filed 2020-08-14
10-Q	2020-03-31	Filed 2020-05-15
S-1	2020-01-23	Public Filing
10-K	2019-12-31	Filed 2020-03-30
10-Q	2019-09-30	Filed 2019-11-19
10-Q	2019-06-30	Filed 2019-08-19
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-04-15
10-Q	2018-09-30	Filed 2018-11-19
10-Q	2018-06-30	Filed 2018-08-17
10-Q	2018-03-31	Filed 2018-05-21
10-K	2017-12-31	Filed 2018-04-17
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-21
10-Q	2017-03-31	Filed 2017-05-22
10-K	2016-12-31	Filed 2017-04-17
10-Q	2016-09-30	Filed 2016-11-21
10-Q	2016-06-30	Filed 2016-08-22
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-12-31	Filed 2016-04-14
10-Q	2015-09-30	Filed 2015-11-23
10-Q	2015-06-30	Filed 2015-08-19
10-Q	2015-03-31	Filed 2015-05-15
10-K	2014-12-31	Filed 2015-04-15
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-08-19
10-Q	2014-03-31	Filed 2014-06-23

Reports

8-K	2021-02-09	Enter Agreement
8-K	2021-01-14	Officers, Exhibits
8-K	2020-12-22	Enter Agreement
8-K	2020-12-07	Enter Agreement, Off-BS Arrangement, Exhibits
8-K	2020-11-20	Enter Agreement, Exhibits
8-K	2020-10-26
8-K	2020-10-23
8-K	2020-10-20
8-K	2020-10-20
8-K	2020-09-30
8-K	2020-09-25
8-K	2020-08-28
8-K	2020-08-27
8-K	2020-08-25
8-K	2020-07-30
8-K	2020-07-29
8-K	2020-07-17
8-K	2020-05-28
8-K	2020-05-11
8-K	2020-03-27
8-K	2019-09-24
8-K	2019-07-12
8-K	2019-07-10
8-K	2019-05-31
8-K	2019-04-05
8-K	2019-03-13
8-K	2019-01-18
8-K	2018-11-12
8-K	2018-06-13
8-K	2018-05-10
8-K	2018-04-18
8-K	2018-01-19
8-K	2018-01-03

1847 Holdings Financials

EFSH Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS)	40,869	77%	-17.5	-11%	226,103	289,374	72,620	55,706	-24,956	-13,928	243,484
Clovis Oncology (CLVS)	219,222	0%	-0.0	-56%	716,892	804,387	134,050	0	-400,184	-394,255	17,741
Cementos Pacasmayo Saa (CPAC)	4,145,433			0%	2,863,245	1,411,882	0	0	0	0	4,145,433
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ)	122,881		1.0	0%	961,684	868,577	0	0	3,422	14,772	14,360
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-06-30	2019-09-30
Cash	0	13	0	0	0	0	0	0	0	0	0	0	169	287	501	78	98	9	334	318	197
Accounts Receivable	25	38	50	62	75	88	100	100	100	100	100	0	300	261	310	94	299	245	550	2,588	1,790
Inventory													562	566	837	771	747	858	488	2,688	2,571
PP&E													6,539	7,429	7,213	7,128	6,954	6,954	6,931	7,129	7,132
Assets	40	51	57	63	75	113	101	101	101	100	100	0	8,067	7,904	8,084	6,949	6,595	6,355	6,052	19,469	18,527
Accounts Payable
Long-Term Debt													4,381	324	58	55	3,503	3,297	3,262	3,822	3,593
Liabilities	53	128	148	252	305	385	454	501	540	584	628	670	7,170	9,654	8,570	8,228	8,298	8,485	8,079	22,957	23,194
Stockholders' Equity	-13	-77	-91	-189	-230	-272	-353	-400	-439	-484	-528	-670	1,287	-1,202	-485	-1,278	-1,703	-2,130	-2,027	-3,488	-4,668


Income Statement ($'000)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-06-30	2019-09-30
Revenue	44	44	44	44	44	44	44	0	0	0	0	0	1,788	1,205	2,756	763	1,470	1,467		12,208	13,544
Cost of Revenue													1,553	1,563				478		9,332	10,710
Gross Profit													235	-358				988		2,876	2,835
R&D
SG&A	44	44	45	45	45	45	46	2	2	2	2	102	803	695	506	535	375	281		1,711	1,964
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	-407	-424	0	0	0		-5	-396
Net Income	-2	-64	-14	-98	-41	-42	-81	-47	-39	-45	-44	-142	1,611	-745	413	-793	-425	-426		-1,256	-1,180


Cash Flow ($'000)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-06-30	2019-09-30
Cash Operating	-0	-13	-19	5	-12	-26	-11	-6	4	-11	-2	-2		-320	-217	-183	-896	4			-502
Cash Investing	0													-287	-400	36	165	0			-152
Cash Financing	0	26	6	-5	12	27	10	6	4	2	2	2		724	832	-275	752	-93			533